US Stock MarketDetailed Quotes

ANVS Annovis Bio

Watchlist
  • 9.090
  • -0.190-2.05%
Close Nov 1 16:00 ET
  • 9.090
  • 0.0000.00%
Post 20:02 ET
118.66MMarket Cap-1652P/E (TTM)

Annovis Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
64.86%-3.38M
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
Net income from continuing operations
47.36%-5.02M
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
Operating gains losses
---4.06M
---6.7M
--11.84M
----
----
----
----
----
----
----
Change In working capital
271.57%2.81M
110.73%368.12K
79.89%-228.6K
-95.15%128.83K
5,210.59%4.71M
38.37%-1.64M
-180.65%-3.43M
-272.95%-1.14M
901.10%2.66M
-72.16%88.78K
-Change in prepaid assets
113.80%3.63M
80.53%-222.78K
143.54%3.19M
76.71%-585.38K
383.18%3.22M
166.17%1.7M
-2.78%-1.14M
-2,606.51%-7.33M
-1,988.84%-2.51M
-1,580.63%-1.14M
-Change in payables and accrued expense
75.65%-812.68K
125.83%590.91K
-155.22%-3.42M
-86.19%714.21K
21.50%1.49M
-3,314.72%-3.34M
-1,990.87%-2.29M
567.15%6.19M
1,240.20%5.17M
407.12%1.23M
Cash from discontinued investing activities
Operating cash flow
64.86%-3.38M
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-50.58%4.24M
59,675.25%4.42M
375,888.10%17.34M
8.76M
0
8.57M
60.11%7.39K
-99.99%4.61K
0
0
Net common stock issuance
-50.58%4.24M
--3.88M
--16.89M
--8.31M
--0
--8.57M
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
7,211.13%540K
9,836.81%458.39K
--450K
--0
--1K
60.11%7.39K
-95.15%4.61K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-50.58%4.24M
59,675.25%4.42M
375,888.10%17.34M
--8.76M
--0
--8.57M
60.11%7.39K
-99.99%4.61K
--0
--0
Net cash flow
Beginning cash position
-81.28%3.14M
-79.72%5.75M
-37.89%28.38M
-80.13%6.35M
-56.29%15.72M
-60.72%16.76M
-37.89%28.38M
465.80%45.69M
-32.60%31.99M
-26.92%35.97M
Current changes in cash
183.24%860.8K
77.47%-2.62M
-30.71%-22.62M
83.37%-600.22K
-135.00%-9.37M
84.55%-1.03M
-285.09%-11.62M
-146.02%-17.31M
-104.00%-3.61M
-125.41%-3.99M
End cash Position
-74.58%4M
-81.28%3.14M
-79.72%5.75M
-79.72%5.75M
-80.13%6.35M
-56.29%15.72M
-60.72%16.76M
-37.89%28.38M
-37.89%28.38M
-32.60%31.99M
Free cash flow
64.86%-3.38M
39.51%-7.03M
-130.85%-39.97M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-89.58%-17.31M
-104.00%-3.61M
-128.70%-3.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 64.86%-3.38M39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M
Net income from continuing operations 47.36%-5.02M89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M
Operating gains losses ---4.06M---6.7M--11.84M----------------------------
Change In working capital 271.57%2.81M110.73%368.12K79.89%-228.6K-95.15%128.83K5,210.59%4.71M38.37%-1.64M-180.65%-3.43M-272.95%-1.14M901.10%2.66M-72.16%88.78K
-Change in prepaid assets 113.80%3.63M80.53%-222.78K143.54%3.19M76.71%-585.38K383.18%3.22M166.17%1.7M-2.78%-1.14M-2,606.51%-7.33M-1,988.84%-2.51M-1,580.63%-1.14M
-Change in payables and accrued expense 75.65%-812.68K125.83%590.91K-155.22%-3.42M-86.19%714.21K21.50%1.49M-3,314.72%-3.34M-1,990.87%-2.29M567.15%6.19M1,240.20%5.17M407.12%1.23M
Cash from discontinued investing activities
Operating cash flow 64.86%-3.38M39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -50.58%4.24M59,675.25%4.42M375,888.10%17.34M8.76M08.57M60.11%7.39K-99.99%4.61K00
Net common stock issuance -50.58%4.24M--3.88M--16.89M--8.31M--0--8.57M--0--0--0--0
Proceeds from stock option exercised by employees --07,211.13%540K9,836.81%458.39K--450K--0--1K60.11%7.39K-95.15%4.61K--0--0
Cash from discontinued financing activities
Financing cash flow -50.58%4.24M59,675.25%4.42M375,888.10%17.34M--8.76M--0--8.57M60.11%7.39K-99.99%4.61K--0--0
Net cash flow
Beginning cash position -81.28%3.14M-79.72%5.75M-37.89%28.38M-80.13%6.35M-56.29%15.72M-60.72%16.76M-37.89%28.38M465.80%45.69M-32.60%31.99M-26.92%35.97M
Current changes in cash 183.24%860.8K77.47%-2.62M-30.71%-22.62M83.37%-600.22K-135.00%-9.37M84.55%-1.03M-285.09%-11.62M-146.02%-17.31M-104.00%-3.61M-125.41%-3.99M
End cash Position -74.58%4M-81.28%3.14M-79.72%5.75M-79.72%5.75M-80.13%6.35M-56.29%15.72M-60.72%16.76M-37.89%28.38M-37.89%28.38M-32.60%31.99M
Free cash flow 64.86%-3.38M39.51%-7.03M-130.85%-39.97M-159.46%-9.36M-135.00%-9.37M-43.49%-9.61M-284.75%-11.63M-89.58%-17.31M-104.00%-3.61M-128.70%-3.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data